Evidence map›Paper›PMID 41854768›Full record

Trial reportSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026

Supportive care: Comparing exercise interventions for upper extremity polyneuropathy induced by chemo- or immunotherapy - VISCIPH B.

Stefanie Siebert, Jane Kersten, Sarah Man, Sarina Heinz, Katharina Leuchte, Freerk T Baumann, Timo Sonntag

Abstract readRandomized Controlled TrialComparative Study
In one paragraph

Trial report in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Stefanie SiebertDepartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Kerpener Str. 62, Cologne, 50937, Germany. stefanie.siebert@uk-koeln.de.
Jane KerstenDepartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Kerpener Str. 62, Cologne, 50937, Germany.
Sarah ManDepartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Kerpener Str. 62, Cologne, 50937, Germany.
Sarina HeinzDepartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Kerpener Str. 62, Cologne, 50937, Germany.
Katharina LeuchteDepartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Kerpener Str. 62, Cologne, 50937, Germany.
Freerk T BaumannDepartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Kerpener Str. 62, Cologne, 50937, Germany.
Timo SonntagDepartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University Hospital of Cologne, Kerpener Str. 62, Cologne, 50937, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChemotherapy and immunotherapy-induced peripheral neuropathy affects up to 68% of cancer patients and may persist long after treatment, substantially impairing daily functioning and quality of life. While exercise therapy has demonstrated benefits in lower-limb polyneuropathy (PNP), evidence for upper-extremity symptoms remains scarce. The VISCIPH B pilot study investigated the effect of two supervised exercise interventions for PNP of the upper extremities using exploratory analyses of symptom response.

methodsIn this single-center randomized controlled pilot trial (DRKS00023287), 61 cancer patients with symptomatic upper-extremity PNP were randomized (1:1) to either (a) combined sensorimotor plus vibration exercise (PNPEX) or (b) moderate resistance exercise (MREX). Both interventions were carried out supervised twice weekly over 12 weeks. Feasibility outcomes included adherence, retention, assessment completeness, and safety of the exercise interventions. Symptom outcomes were assessed with the FACT/GOG-Ntx questionnaire, measures of pain (NRS), depth sensitivity (Rydel-Seiffer tuning fork), and quality of life (EORTC QLQ-C30).

resultsFeasibility criteria showed high adherence (86%) and retention (69%) rates. A total of 42 patients (mean age 53.3 years, 36% male) completed the intervention with no reported intervention-related adverse events. In the exploratory effect analyses, 50% of PNPEX participants (10/20) were classified as responders, compared to 14% (3/21) in MREX (OR = 5.45, p = 0.043). FACT/GOG-Ntx scores improved significantly in PNPEX (p = 0.017) but not in MREX (p = 0.46), resulting in a significant difference between the two groups (p = 0.05). Patient-reported outcomes revealed significant improvements in the PNPEX group regarding numbness and tingling (NRS), depth sensitivity at four of the eight tested bone sites and global health (p = 0.001).

conclusionThe VISCIPH B pilot trial confirmed the feasibility, safety, and acceptance of supervised exercise for upper-extremity PNP in cancer patients. Significant improvements in patient-reported and functional outcomes indicate that combined sensorimotor and vibration exercise can meaningfully reduce PNP symptoms and should be evaluated in larger trials.

Indexed as

Antineoplastic AgentsExercise TherapyImmunotherapyPolyneuropathiesAdultAgedFeasibility StudiesFemaleHumansMaleMiddle AgedNeoplasmsPilot ProjectsQuality of LifeUpper ExtremityVibrationAntineoplastic AgentsCancer treatment toxicitySensorimotor exerciseSupportive careTherapy-induced peripheral neuropathyUpper extremitiesVibration intervention

Identifiers

PMID41854768
PMCPMC13002742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.